102 related articles for article (PubMed ID: 30331822)
1. Rotation Saw, Newly Invented by Professor Thal of Copenhagen.
Howitz F
Edinb Med Surg J; 1823 Jan; 19(74):55-57. PubMed ID: 30331822
[No Abstract] [Full Text] [Related]
2. A Description of a New Instrument for Tying Arteries without the Aid of an Assistant, Invented by Professor Ludwig Jacobson of Copenhagen, and Communicated by Him to the Royal Medical Society of That City in the Year 1817.
Stedman GW
Edinb Med Surg J; 1824 Apr; 21(79):313-315. PubMed ID: 30331879
[No Abstract] [Full Text] [Related]
3. [Thalassemic alleles in Mexican mestizos].
Ibarra B; Perea FJ; Villalobos-Arámbula AR
Rev Invest Clin; 1995; 47(2):127-31. PubMed ID: 7610281
[TBL] [Abstract][Full Text] [Related]
4. Thalidomide in multiple myeloma.
Moehler TM; Hillengass J; Glasmacher A; Goldschmidt H
Curr Pharm Biotechnol; 2006 Dec; 7(6):431-40. PubMed ID: 17168659
[TBL] [Abstract][Full Text] [Related]
5. Celebrating the centennial (1894-1994): Leonardo Gigli and his wire saw.
Brunori A; Bruni P; Greco R; Giuffré R; Chiappetta F
J Neurosurg; 1995 Jun; 82(6):1086-90. PubMed ID: 7760186
[TBL] [Abstract][Full Text] [Related]
6. [The efficacy of thalidomide for multiple myeloma: a clinical analysis of 102 Chinese patients].
Qi PJ; Wang YF; Xu Y; Li YN; Zou DH; Zhao YZ; Xiao ZJ; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):226-9. PubMed ID: 18843974
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
Dingli D; Rajkumar SV; Nowakowski GS; Gertz MA; Dispenzieri A; Lacy MQ; Hayman S; Fonseca R; Lust JA; Kyle RA; Greipp PR; Witzig TE
Haematologica; 2005 Dec; 90(12):1650-4. PubMed ID: 16330438
[TBL] [Abstract][Full Text] [Related]
8. Description of New Surgical Instruments Invented by Professor Assalini.
Want
Lond Med Phys J; 1815 Jul; 34(197):2-6. PubMed ID: 30493706
[No Abstract] [Full Text] [Related]
9. Beta-thalassemia associated with alpha-thalassemia in Thailand.
Fucharoen S; Winichagoon P; Thonglairuam V
Hemoglobin; 1988; 12(5-6):581-92. PubMed ID: 3209400
[TBL] [Abstract][Full Text] [Related]
10. [The prevalence of beta-thalassemia heterozygotes compound alpha-thalassemia in Guangdong district].
Han J; Zeng R; Hu B
Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):514-6. PubMed ID: 11769674
[TBL] [Abstract][Full Text] [Related]
11. Clinical severity of non-deletion form of HbH disease (--Med/alpha alpha thal).
Di Marzo R; Lo Gioco P; Giambona A; Acuto S; Sammarco P; Oddo G; Maggio A
Scand J Haematol; 1986 Jan; 36(1):39-43. PubMed ID: 3006223
[TBL] [Abstract][Full Text] [Related]
12. beta+-Thalassemia trait: hematologic and hemoglobin synthesis studies.
Pootrakul S; Assawamunkong S; Na-Nakorn S
Hemoglobin; 1976-1977; 1(1):75-83. PubMed ID: 1052172
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of beta-thalassemia and other hemoglobinopathies in Bulgaria: an update.
Petkov GH; Efremov GD
Hemoglobin; 2007; 31(2):225-32. PubMed ID: 17486505
[TBL] [Abstract][Full Text] [Related]
14. Common alpha-thalassemia deletions in transfusion-dependent thalassemia patients in the Southeast Asia region of Myanmar.
Ne-Win ; Harano K; Harano T; Thein-Thein-Myint ; Rai-Mra ; Aye-Aye-Myint ; Shimono K; Okada S
Lab Hematol; 2006; 12(3):139-42. PubMed ID: 16950674
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and mutations of β-thalassemia trait and abnormal hemoglobins in premarital screening in Çanakkale province, Turkey.
Uludağ A; Uysal A; Uludağ A; Ertekin YH; Tekin M; Kütük B; Silan F; Özdemir Ö
Balkan J Med Genet; 2016 Jul; 19(1):29-34. PubMed ID: 27785405
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of the - -(SEA), - -(THAI) and - -(FIL) α-Thalassemia-1 Carriers from a 7-Year Study at Ramathibodi Hospital, Bangkok, Thailand.
Pongjantharasatien K; Banyatsuppasin W; Pounsawat S; Jindadamrongwech S
Hemoglobin; 2016 Aug; 40(4):283-4. PubMed ID: 27492767
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma.
Dimopoulos MA; Kastritis E
Nat Clin Pract Oncol; 2008 Dec; 5(12):690-1. PubMed ID: 18779849
[TBL] [Abstract][Full Text] [Related]
18. Oxidation status of β-thalassemia minor and Hb H disease, and its association with glycerol lysis time (GLT50).
Adhiyanto C; Hattori Y; Yamashiro Y; Mella F; Nitta T; Iihoshi M; Araki S; Matar M; Takagi F
Hemoglobin; 2014; 38(3):169-72. PubMed ID: 24611654
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with thalidomide and lenalidomide in multiple myeloma.
Moehler T
Curr Cancer Drug Targets; 2012 May; 12(4):372-90. PubMed ID: 22229246
[TBL] [Abstract][Full Text] [Related]
20. Globin chain synthesis is a useful complementary tool in the differential diagnosis of thalassemias.
Khatami S; Dehboneh SR; Sadeghi S; Mirzazadeh R; Saeedi P; Bayat P; Najmabadi H; Zeinali S; Akbari MT; Ardjmand M; Amirkhani A
Hemoglobin; 2007; 31(3):333-41. PubMed ID: 17654070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
